FDA Inspection
Etex CorporationFDA Inspection 1059083 - Etex Corporation - July 16, 2018
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
This FDA Inspection record concerns Etex Corporation, with an inspection on July 16, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · debb1651-2420-4347-b723-e6491fee989b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1059083
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Etex Corporation
5| Date | Classification | Office | Project area |
|---|---|---|---|
| September 25, 2024 | Not classified | New England District Office | |
| May 23, 2019 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 19, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| February 15, 2013 | VAI | Center for Devices and Radiological Health | Compliance: Devices |
| September 29, 2010 | VAI | Center for Devices and Radiological Health | Compliance: Devices |